When diabetes mellitus occurs in a child or adolescent under 18 years old who has Friedreich ataxia, standard pediatric diabetes management may not apply. A dedicated evidence-based protocol exists for this specific clinical combination.
Patient is under 18 years of age with Friedreich ataxia and concurrent diabetes mellitus. The presence of diabetes in this neurodegenerative context requires a targeted treatment approach distinct from typical pediatric diabetes care.
The protocol directs an insulin-based strategy as the primary modality for glycemic management in this population. Important guidance exists regarding which additional glucose-lowering options to include or exclude — details are in the full protocol.
Complete regimen, sequencing, and clinical rationale are available behind the link below.
DOI: 10.1186/s13023-022-02568-3
We suggest using insulin alone rather than insulin and other glucose-lowering therapy as the primary treatment for most children (under 18 years old) with Friedreich ataxia-related diabetes mellitus.
View source ↗